Ecolab Unveils Purolite AP+50 Resin to Enhance Cost-Efficiency and Performance in Antibody Manufacturing at BIO 2025

Ecolab Life Sciences announced it has launched an innovative new resin to help achieve cost savings and optimize operations throughout the antibody manuf...

June 17, 2025 | Tuesday | News
BioAro Launches PanOmiQ™ Research, Setting a New Standard for AI-Driven Multi-Omics and Drug Discovery

AI meets genomics in BioAro’s latest launch, unlocking faster, scalable drug discovery.PanOmiQ™ Research sets a new global benchmark for prec...

June 17, 2025 | Tuesday | News
Integrated DNA Technologies Expands Infectious Disease Portfolio With Advanced Solutions for Global Research and Surveillance

Integrated DNA Technologies (IDT), a global genomics leader, is expanding its infectious disease portfolio with new solutions to enhance worldwide research...

June 17, 2025 | Tuesday | News
Enzene Adds 26,000 Sq. Ft. to NJ Facility, Unveils Expansion at BIO 2025

Enzene, a pioneer in fully-connected continuous biologics manufacturing technology, announced that ahead of the official opening of its biologics manufactu...

June 17, 2025 | Tuesday | News
Sarepta Halts ELEVIDYS Shipments for Non-Ambulatory Duchenne Patients After Second Fatal Case of Acute Liver Failure

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today provided a safety update regarding ELEVIDYS (...

June 16, 2025 | Monday | News
Volta Labs Launches Automated Library Prep App for Oxford Nanopore on Callisto System

Volta Labs, a genomics applications company,  announced the launch of its Library Prep App for Oxford Nanopore LSK114 on the Callisto™ Sample ...

June 13, 2025 | Friday | News
Taiwan Showcases Precision Medicine and Biomanufacturing Strength at BIO 2025 with 35 Firms and Global Start-Up Finalists

Taiwan's delegation, led by BPIPO (Biotechnology and Pharmaceutical Industries Promotion Office), organized by the Ministry of Economic Affairs, and...

June 13, 2025 | Friday | News
BioAegis Advances Phase 2 Study of rhu-pGSN to Combat Decompression Sickness in SCUBA Divers

Phase 2 proof-of-concept study for rhu-pGSN, a promising intervention across a spectrum of inflammatory diseases, to be studied as an intervention for th...

June 12, 2025 | Thursday | News
Cytiva Accelerates Bioprocessing Supply with $1.6B Global Manufacturing Expansion

  Faster delivery and productivity gains available thanks to expanded manufacturing capacity in chromatography resins, filtration, single-use bag...

June 12, 2025 | Thursday | News
EDETEK Partners with Capgemini to Accelerate AI-Driven Digital Transformation in Clinical Development

  EDETEK Inc., a global provider of leading AI-driven clinical development platforms and services, has engaged Capgemini to support its ongoing advan...

June 11, 2025 | Wednesday | News
Yoneda Labs and Symeres Boost Cross-Coupling Reaction Yields from 30 to Over 90 Percent Using AI-Driven Optimization

Yoneda Labs, a leader in computational tools for reaction optimization, has successfully collaborated with Symeres, a leading transatlantic, small molecule...

June 10, 2025 | Tuesday | News
IonQ, AstraZeneca, AWS, and NVIDIA Achieve 20x Speedup in Quantum-Accelerated Drug Development Workflow

Largest demonstration of its kind combines leading hardware, platforms, and techniques to achieve 20 times speedup over previous demonstrations Ecosys...

June 10, 2025 | Tuesday | News
Metsera Reports Positive Phase 1 Results for MET-233i Showing Up to 8.4 Percent Weight Loss and Once-Monthly Dosing Potential

Metsera, Inc. announced positive topline data from the Phase 1 clinical trial of MET-233i, an ultra-long acting amylin analog engineered for class-leadin...

June 10, 2025 | Tuesday | News
OBI Pharma and TegMine Therapeutics Enter ADC Collaboration to Target Cancer-Specific Glycans

OBI Pharma, Inc. (OBI), a clinical-stage global oncology company specialized in the development of novel cancer therapies such as antibody-drug conjugate...

June 10, 2025 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close